MLTX
NASDAQ · Biotechnology
Moonlake Immunotherapeutics
$18.26
+0.23 (+1.28%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-42.3% upside
Low Target
$8.06
Average Target
$10.54
High Target
$16.98
Current Price
$18.26
Current
$18.26
$18.26
Target
$10.54
$10.54
$8.06
$10.54 avg
$16.98
Scenario Analysis
Bear Case
$8.06
-55.9%
Low target
Base Case
$10.54
-42.3%
Avg target
Bull Case
$16.98
+-7.0%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$62.75
-70.9% from high
52-Week Low
$5.95
+206.9% from low
Target vs 52W High
$10.54
-83.2% vs high
Next Earnings Report
Aug 12, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.94
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |